First Metformin Gum Patent Granted to Generex Biotechnology (SYS-CON Media)
First Metformin Gum Patent Granted to Generex Biotechnology (SYS-CON Media)
Generex Biotechnology Corporation (NASDAQ: GNBT),the leader in drug delivery for metabolic diseases through the inner liningof the mouth, announced today that it has been granted the first patent forits medicinal gum platform titled ‘Compositions for Oral TransmucosalDelivery of Metformin.’ The patent covers claims to the composition,processes, and methodologies for the delivery of an oral